Reactive infectious mucocutaneous eruptions associated with SARS-CoV-2 infection

Authors

  • Shaji Thomas John Department of Paediatrics and Dermatology, Baby Memorial Hospital, Calicut, Kerala, India http://orcid.org/0000-0003-4139-6497
  • Gayathri K. Department of Paediatrics and Dermatology, Baby Memorial Hospital, Calicut, Kerala, India
  • Rizwana P. Department of Paediatrics and Dermatology, Baby Memorial Hospital, Calicut, Kerala, India
  • Abhay M. Martin Department of Paediatrics and Dermatology, Baby Memorial Hospital, Calicut, Kerala, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20214953

Keywords:

COVID-19, Reactive infectious mucocutaneous eruptions

Abstract

Several dermatological manifestations are described in COVID-19. A 3-year-old boy presented with fever, painful oral ulcers with COVID-19 infection. A diagnosis of reactive infectious mucocutaneous eruptions (RIME) was made. He was worked up for the usual causes of RIME but were all negative. His severe acute respiratory syndrome corona virus-2 immunoglobulin M (SARS-CoV-2 IgM) was positive and he was managed with Intravenous hydrocortisone with which he improved dramatically. RIME might be the first/only manifestation of COVID-19 and it should be kept in mind.

Author Biographies

Shaji Thomas John, Department of Paediatrics and Dermatology, Baby Memorial Hospital, Calicut, Kerala, India

Department of Paediatrics & Neonatology

Chief of Paediatrics & Neonatology

Chief of Clinical Support Services

Gayathri K., Department of Paediatrics and Dermatology, Baby Memorial Hospital, Calicut, Kerala, India

Consultant in Paediatrics

Rizwana P., Department of Paediatrics and Dermatology, Baby Memorial Hospital, Calicut, Kerala, India

Resident in Paediatrics

Abhay M. Martin, Department of Paediatrics and Dermatology, Baby Memorial Hospital, Calicut, Kerala, India

Chief of Dermatology

References

Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8.

Santosh ABR, Muddana K. Viral infections of oral cavity. J Family Med Prim Care. 2020;9:36-42.

Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR, et al. The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;83(4):1118-29.

Amorim Dos Santos J, Normando AGC, Carvalho da Silva RL, De Paula RM, Cembranel AC, Santos-Silva AR, et al. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? Int J Infect Dis. 2020;97:326-8.

Ramien ML, Bruckner AL. Mucocutaneous eruptions in acutely ill pediatric patients—think of mycoplasma pneumoniae (and other infections) first. JAMA Dermatol. 2020;156(2):124-5.

Song A, Nicholson C, Maguiness S. Recurrent reactive infectious mucocutaneous eruption (RIME) in two adolescents triggered by several distinct pathogens including SARS-CoV-2 and influenza A. Pediatr Dermatol. 2021;00:1-4.

Downloads

Published

2021-12-24

Issue

Section

Case Reports